The effect of L-carnitine administration on doxorubicine induced hepatoxicity and nephrotoxicity in rabbits;L-carnitin uygulamasının tavşanlarda doksorubisin kaynaklı hepatopatoksisite ve nefrotoksisite üzerine etkisi

Kafkas Universitesi Veteriner Fakultesi Dergisi

Volumn 15, Issue 5, 2009, Pages 733-738

  Erdogan, Hidayet Metin ^a   Citil, Mehmet ^a   Tuzcu, Mehmet ^b   Atakisi, Emine ^a   Gunes, Vehbi ^c   Uzlu, Erdogan ^a  

^a KAFKAS UNIVERSITY   (Turkey)

^b Plant Protection Research Institute   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Doxorubucine; Hepatoxicity; L carnitine; Nephrotoxicity; Rabbit

Indexed keywords

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 70449381307     PISSN: 13006045     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Santos RVT, Batirsta Jr ML, Caperuto EC, Costa Rosa LFBP: Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats. Clin Exp Pharmacol Physiol, 34, 1294-1299, 2007.
2. Kalender Y, Yel M, Kalender S: Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology, 209, 39-45, 2005.
3. El-Missiry MA, Othman AI, Amer MA, Abd El-Aziz MA: Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats. Free Radic Res, 35, 575-581, 2001.
4. Zhang J, Clark JR, Herman EH, Ferrans VJ: Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol, 28, 1931-1943, 1996.
5. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez-Tortosa MC: Antioxidant nutrients and adriamycin toxicity. Toxicology, 180, 79-95, 2002.
6. Luo X, Reichetzer B, Trines J, Benson LN, Lehotay DC: L-carnitine attenuates doxorubicin-induced lipid peroxidation in rats. Free Radic Biol Med, 26 (9-10): 1158-1165, 1999.
7. Gianni L, Myers CE: The Role of Free Radical Formation in the Cardiotoxicity of Anthracycline. In, Muggia FM, Green MD, Speyer JL (Eds): Cancer Treatment and the Heart. pp. 9-46. The John Hopkins University Press, Baltimore, 1992.
8. Plaa GL, Witschi H: Chemicals, drugs and lipid peroxidation. Annu Rev Pharmacol Toxicol, 16, 125-141, 1976.
9. Citil M, Erdogan HM, Uzlu E, Atakisi E, Gunes V, Tuzcu M, Uzun M, Doǧan A: Protective effects of L-carnitine on doxorubicine induced cardiomyopathy in rabbits. Kafkas Univ Vet Fak Derg, 14 (2): 229-235, 2008.
10. Boonsanit D, Kanchanapangka S, Buranakarl C: Lcarnitine ameliorates doxorubicin-induced nephrotic syndrome in rats. Nephrology, 11, 313-320, 2006.
11. Karapehlivan M, Uzlu E, Atakisi O, Erdogan HM, Uzun M, Citil M: Doksorubisin uygulanan tavsanlarda plazma sialik asit, malondialdehit ve redükte glutatyon düzeylerine Lkarnitinin etkileri. Kafkas Univ Vet Fak Derg, 13 (2): 155-160. 2007.
12. Bieber LL: Carnitine. Annu Rev Biochem, 57, 261-283, 1988.
13. Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, Inoue M, Utsumi K: Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem Pharmacol, 62 (8): 1037-1046, 2001.
14. Liu J, Atamna H, Kuratsune H, Ames BN: Delaying brain mitochondrial decay and aging with mitochondrial anti- oxidants and metabolites. Ann N Y Acad Sci, 959, 133-166, 2002.
15. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN: Feeding acetyl-L- carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA, 99 (4): 1870-1875, 2002.
16. Pastorino JG, Snyder JW, Serroni A, Hoek JB, Farber JL: Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem, 268 (19): 13791-1398, 1993.
17. Kalaiselvi T, Panneersalvam C: Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J Nutr Biochem, 9, 575-581, 1998.
18. Arockia Rani PJ, Panneerselvam C: L-carnitine as a free radical scavenger in aging. Exp Gerontol, 36, 1713-1726, 2001.
19. Yagmurca M, Bas O, Mollaoglu H, Sahin O, Nacar A, Karaman O, Songur A: Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Arch Med Res, 38 (4): 380-385, 2007.
20. Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A, Cerar A, Strukelj B: Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials, 29, 3451-3460, 2008.
21. Gokcimen A, Cim A, Tola HT, Bayram D, Kocak A, Ozguner F, Ayata A: Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity. Hum Exp Toxicol, 26, 519-525, 2007.
22. Kwiecien I, Michalska M, Wlodek L: The selective effect of cystathionine on doxorubicin hepatotoxicity in tumor- bearing mice. Eur J Pharmacol, 550, 39-46, 2006.
23. Teraoka K, Hirano M, Yamaguchi K, Yamashina A: Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats. Eur J Heart Fail, 2, 373-378 2000.
24. Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB: Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res, 61, 771-777, 2001.
25. Pedrycz A, Wieczorski M, Czerny K: The influence of a single dose of adriamycin on the pregnant rat female liver- histological and histochemical evaluation. Ann Univ Mariae Curie Sklodowska, 59, 319-323, 2004.
26. Zeidan Q, Strauss M, Porras N, Anselmi G: Differential long term subcellular response to heart and liver to adriamycin stress. J Submicrosc Cytol Pathol, 34, 315-321, 2002.
27. Kumar D, Kirshenbaum L, Li T, Danelisen I, Singal P: Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann N Y Acad Sci, 874, 156-168, 1999.
28. Andrieu-Abadie N, Jaffrezou JP, Hatem S, Laurent G, Levade T, Mercadier JJ: L-carnitine prevents doxorubicin- induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation. FASEB J, 13, 1501-1510, 1999.
29. Mansour MA, El-Kashef HA, Al-Shabanah OA: Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res, 39 (3): 233-237, 1999.
30. Pedrycz A, Wieczorski M, Czerny K: Increased apoptosis in the adult rat liver after a single dose of adriamycin administration. Ann UMCS Sect D, 59, 313-318, 2004.
31. Pedrycz A, Boratynski Z, Wieczorski M, Visconti J: Ultrastructural and immunohistochemical evaluation of apoptosis in foetal rat liver after adriamycin administration. Bull Vet Inst Pulawy, 49, 475-479, 2005.
32. Griffin Green EA, Zaleska MM, Erecsinska M: Adriamycin induced lipid peroxidation in mitochondria and microsomes. Biochem Pharmacol, 37, 3071-3077, 1988.
33. Di Marzio L, Alesse E, Roncaioli P, Muzi P, Moretti S, Marcellini S, Amicosante G, De Simone C, Cifone MG: Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases invitro. Proc Assoc Am Physicians, 109, 154-163, 1997.